Inflammatory Disease Manufacturers, Suppliers & Companies
-
Manufacturerbased in Yongin, SOUTH KOREA
Bilix is established based on the world’s first PEGylated bilirubin platform technology to produce numerous “First in Class” in anti-inflammatory and “Best in Class” in cancer therapy drugs in addition to achieving other business platform such as ...
BRIXELLE-INFLA - Many Inflammatory Diseases
Many inflammatory diseases are associated with reactive oxygen species(ROS) in the body. The bilirubin nanoparticle has strong antioxidant, ROS scavenging, and immune modulating properties which effectively ...
CONTACT SUPPLIER -
Manufacturerbased in Rueil-Malmaison Cedex, FRANCE
At Advanced Accelerator Applications (AAA), we are reimagining nuclear medicine and cancer care. Our mission is to transform patients’ lives by developing and delivering targeted radioligand therapies and precision imaging radioligands for oncology. ...
Gluscan / Barnascan - Infectious and Inflammatory Diseases Used PET Tracer
AAA brand names for FDG (most widely used PET tracer): Oncology, cardiology, neurology. Infectious and inflammatory ...
CONTACT SUPPLIER -
Manufacturerbased in Somerville, MASSACHUSETTS (USA)
Finch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs. With the capabilities to develop both complete and targeted ...
Finch - Model TAK-524 & FIN-525 - Microbiome Therapeutics for Inflammatory Bowel Disease (IBD)
In collaboration with Takeda Pharmaceuticals, we are developing FIN-524 and FIN-525, orally administered, Targeted Consortia product candidates designed for the treatment of ulcerative colitis (UC) and Crohn’s disease (CD), ...
CONTACT SUPPLIER -
Technologybased in Saint Kevin`s, IRELAND
At Horizon, we believe science and compassion must work together to transform lives. Our mission to deliver medicines for rare, autoimmune and severe inflammatory diseases and provide compassionate support comes from our strong and simple philosophy ...
Alpine - Multi-Specific Fusion Protein
Exclusive collaboration to develop novel, multi-specific fusion protein based therapies for autoimmune and inflammatory ...
CONTACT SUPPLIER -
Technologybased in Rockville, MARYLAND (USA)
Since the treatment of our first oncology patient in 2015, AbelZeta has been able to build best-in-class and best-in-disease potential pipeline, leading to the licensing of two CD20-directed autologous CAR-Ts to Janssen Biotech in 2023. Our goal is ...
Model C-CAR168 - Inflammatory & Immunological Diseases
PRODUCT: C-CAR168. INDICATION: Autoimmune. PLATFORM: CAR-T. PRECLINICAL: CD20 / BCMA. IIT: -. PHASE 1/1B: -. PHASE 2: -. PARTNERS: ...
CONTACT SUPPLIER -
Manufacturerbased in Buk-gu, SOUTH KOREA
JD Bioscience (JDB) is a group of experts in small molecule-based novel drug development. JD Bioscience was established by a team of highly experienced medicinal chemists, biologists, and clinicians in the field of endocrine and metabolic diseases. ...
JDB - Inflammatory Bowel Disease (IBD)
IBD, including ulcerative colitis (UC) and crohn’s disease (CD) can be caused by genetic and environmental factors and can induces uncontrolled activation of intestinal immune cells. Pro-inflammatory ...
CONTACT SUPPLIER -
Manufacturerbased in Dijon, FRANCE
At Exeliom Biosciences, we develop novel therapeutic approaches to unleash the therapeutic potential of key players in the Microbiome - Host interactions to fight immune-mediated diseases, starting with inflammatory bowel diseases. There is a time ...
Model exl01 - Single Bacterial Strain Drug
Our research has led us to discover that patients suffering from inflammatory bowel diseases lack a crucial bacterium and, therefore, do not have a fair chance to fight their conditions. We have developed a single ...
CONTACT SUPPLIER -
Manufacturerbased in Kadima, ISRAEL
InnVentis is creating proprietary molecular and real-world reference databases, algorithms, and a safe/secure ICT architecture to allow precise real-time. Pharma and nutraceuticals: Today, 50% of drugs fail in late stage development due to lack of ...
InnVentis - Comprehensive Personal Molecular Profile Technology
The InnVentis technology platform combines data of unprecedented quality and depth with cutting-edge algorithms to create actionable ...
CONTACT SUPPLIER -
Software vendorbased in Boston, MASSACHUSETTS (USA)
Accelerating Discovery in CNS, Cardiometabolic and Inflammatory Disease. We support our clients to achieve more in their target & biomarker programs. Our expertise, curated & disease enriched clinco-omic cohorts, tools and applications for insight ...
-
Service providerbased in heongju-si, SOUTH KOREA
Curome Biosciences is an innovative R&D company developing therapies to treat mitochondrial dysfunction-related diseases with high unmet medical needs. Curome Biosciences wants to provide solutions for treatment of diseases with high unmet medical ...
Researching Services
the increase in NAD+, an essential cofactor of the redox reaction in cells. The goal is development of innovative new drug for metabolic diseases, rare diseases and refractory inflammatory ...
CONTACT SUPPLIER -
Manufacturerbased in Cambridge, MASSACHUSETTS (USA)
Seres Therapeutics is a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human ...
-
Manufacturerbased in Seattle, WASHINGTON (USA)
Aptevo Therapeutics is a biotech company focused on bringing novel immuno-oncology therapeutics to market. We leverage the innovative ADAPTIR™ and ADAPTIR-FLEX platform technologies to create therapeutic candidates designed to improve outcomes for ...
-
Manufacturerbased in Paris, FRANCE
Enterome is pioneering the discovery and development of novel pharmaceuticals based on its unrivalled understanding of the interaction between the gut microbiome and the immune system – the Microbiome-Immunoinflammation Axis. Enterome is using this ...
Enterome - Model EB1010 - IBD, Food Allergy
EB1010 is an orally administered, GI-selective next generation IL-10 inducer designed to induce high local secretion of IL-10 for the treatment of Inflammatory Bowel Disease (IBD) and food allergy. EB1010 is a ...
CONTACT SUPPLIER -
Manufacturerbased in Jenkintown, PENNSYLVANIA (USA)
SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease – the use of microbiome-derived metabolites as drugs. A completely new approach to drug ...
Microbiome
SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease – the use of microbiome-derived metabolites as ...
CONTACT SUPPLIER -
Technologybased in Paris, FRANCE
Abivax develops innovative treatments modulating the body’s natural immune system machinery to treat patients with chronic inflammatory diseases, viral infections and cancer. As a clinical-stage company, Abivax leverages its immune enhancing and ...
-
Technologybased in Basel, SWITZERLAND
Aurealis Therapeutics, a Swiss-Finnish private biopharmaceutical company, is now entering the clinical trial phase with its patented three-in-one combination product AUP-16 for chronic non-healing wounds and other regenerative diseases. The ...
-
Manufacturerbased in Lausanne, SWITZERLAND
AB2 Bio Ltd., located at the Innovation Park of the École Polytechnique Fédérale de Lausanne (EPFL), is a drug discovery and development company focused on developing “best in class” innovative therapies for the treatment of inflammatory diseases ...
AB2 Bio - Model Tadekinig alfa (IL-18BP) - Interleukin-18 Binding Protein
Tadekinig alfa is a recombinant Interleukin-18 Binding Protein (r-hIL-18BP) with a high affinity for IL-18, a major inflammatory cytokine. In healthy people, there is a large excess of naturally occurring IL-18BP keeping levels of ...
CONTACT SUPPLIER -
Technologybased in Bundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
-
Manufacturerbased in Irvine, CALIFORNIA (USA)
We are a global biomedical technology company that offers advanced in-vitro diagnostic solutions. We develop, patent, manufacture and market IVD products. Our primary research and development focus is on gastrointestinal and inflammatory diseases ...
-
Manufacturerbased in Oranmore, IRELAND
Neurent Medical is dedicated to developing highly innovative non-surgical interventions that treat chronic inflammatory Sino-Nasal diseases. The privately held, venture backed company is based in Galway Ireland. Neurent Medical was founded by CEO ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you